Company: LBRX
Filing Date: 2025-08-22
Form Type: S-1
Source: 0001193125-25-186467
Chunk: 269

Company: LB PHARMACEUTICALS INC
Filing Date: 2025-08-22
Form: S-1
Chunk 269
---
2017 Plan, 2018 Plan, and our 2023 Plan. Following this offering, we
will grant equity incentive awards under the terms of our 2025 Plan. The terms of our equity plans are described below under “—Equity Benefit Plans.” All options are granted with a per share exercise price equal to no less than the
fair market value of a share of our common stock on the date of the grant of such award. Generally, our option awards vest over a four-year period subject to the holder’s continuous service to us, as further described under
“—Outstanding Equity Awards as of December 31, 2024” below.

In June 2024, our board of directors granted
Mr. Prensky, Mr. Sawhney, and Dr. Eramo options to purchase 1,500,000, 950,000, and 175,000 shares of our common stock, respectively. In addition, in November 2024, our board of directors granted Ms. Turner an option to
purchase 4,900,000 shares of our common stock. The terms of these awards are described under “—Outstanding Equity Awards as of December 31, 2024” below.

185

Outstanding Equity Awards as of December 31, 2024 The following table sets forth certain information regarding equity awards granted to our named executive officers that remained outstanding as of December 31, 2024.

|                    |     |            |            |     | Option Awards(1) |         |     |               |           |    |     |          |      |     |            |            |     | Stock Awards(1) |   |     |          |   |
| Name               |     | Grant Date |            |     | Number of        
 Securities       
 Underlying       
 Unexercised      
 Options (#)      
 Exercisable      |         |     | Number of     
 Securities    
 Underlying    
 Unexercised   
 Options (#)   
 Unexercisable |           |    |     | Option   
 Exercise 
 Price    
 ($)      |      |     | Option     
 Expiration 
 Date       |            |     | Number          
 of Shares       
 or Units        
 of Stock        
 that            
 Have            
 Not             
 Vested          
 (#)             |   |     | Market   
 Value of 
 Shares   
 or Units 
 of       
 Stock    
 That     
 Have Not 
 Vested   
 ($)(2)   |   |
| Heather Turner     |     |            |